Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer
about
Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses.Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma.Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma.Clinical Pharmacokinetic and Pharmacodynamic Profile of Lenvatinib, an Orally Active, Small-Molecule, Multitargeted Tyrosine Kinase Inhibitor.
P2860
Population pharmacokinetic analysis of lenvatinib in healthy subjects and patients with cancer
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Population pharmacokinetic ana ...... jects and patients with cancer
@en
type
label
Population pharmacokinetic ana ...... jects and patients with cancer
@en
prefLabel
Population pharmacokinetic ana ...... jects and patients with cancer
@en
P2093
P2860
P356
P1476
Population pharmacokinetic ana ...... jects and patients with cancer
@en
P2093
Anubha Gupta
Jaume Capdevila
Ziad Hussein
P2860
P304
P356
10.1111/BCP.12907
P407
P577
2016-02-15T00:00:00Z